Literature DB >> 26745609

Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity.

Jay H Lubin1, David Couper, Pamela L Lutsey, Mark Woodward, Hiroshi Yatsuya, Rachel R Huxley.   

Abstract

BACKGROUND: Relative risks (RRs) for cardiovascular disease (CVD) by smoking rate exhibit a concave pattern, with RRs in low rate smokers exceeding a linear extrapolation from higher rate smokers. However, cigarettes/day does not by itself fully characterize smoking-related risks. A reexamination of the concave pattern using a comprehensive representation of smoking may enhance insights.
METHODS: Data were from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort enrolled in four areas of the US in 1987-1989. Follow-up was through 2008. Analyses included 14,233 participants, 245,915 person-years, and 3,411 CVD events.
RESULTS: The concave RRs with cigarettes/day were consistent with cigarettes/day modifying a linear RR association of pack-years with CVD (i.e., strength of the pack-years association depended on cigarettes/day, indicating that the manner of pack-years accrual impacted risk). Smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration (P < 0.01). For 50 pack-years (365,000 cigarettes), estimated RRs of CVD were 2.1 for accrual at 20 cigarettes/day and 1.6 for accrual at 50 cigarettes/day. Years since smoking cessation did not alter the diminishing strength of association with increasing cigarettes/day. Analyses that accounted for competing risks did not affect findings.
CONCLUSION: Pack-years remained the primary determinant of smoking-related CVD risk; however, accrual influenced RRs. For equal pack-years, smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration. This observation provides clues to better understanding the biological mechanisms, and reinforces the importance of cessation rather than smoking less to reduce CVD risk.

Entities:  

Mesh:

Year:  2016        PMID: 26745609      PMCID: PMC5482174          DOI: 10.1097/EDE.0000000000000437

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  36 in total

1.  Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers.

Authors:  Richard J O'Connor; Gary A Giovino; Lynn T Kozlowski; Saul Shiffman; Andrew Hyland; John T Bernert; Ralph S Caraballo; K Michael Cummings
Journal:  Am J Epidemiol       Date:  2006-08-03       Impact factor: 4.897

2.  Invited commentary: is it time to retire the "pack-years" variable? Maybe not!

Authors:  Duncan C Thomas
Journal:  Am J Epidemiol       Date:  2013-12-18       Impact factor: 4.897

3.  Measurement of self reported active exposure to cigarette smoke.

Authors:  J F Etter; T V Perneger
Journal:  J Epidemiol Community Health       Date:  2001-09       Impact factor: 3.710

4.  Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Authors:  J P Richie; S G Carmella; J E Muscat; D G Scott; S A Akerkar; S S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

5.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer.

Authors:  M R Law; J K Morris; H C Watt; N J Wald
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Air pollution combustion emissions: characterization of causative agents and mechanisms associated with cancer, reproductive, and cardiovascular effects.

Authors:  Joellen Lewtas
Journal:  Mutat Res       Date:  2007-08-17       Impact factor: 2.433

7.  The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics.

Authors:  Jay H Lubin; Neil Caporaso; Dorothy K Hatsukami; Anne M Joseph; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 8.  Environmental tobacco smoke and ischemic heart disease.

Authors:  Malcolm R Law; Nicholas J Wald
Journal:  Prog Cardiovasc Dis       Date:  2003 Jul-Aug       Impact factor: 8.194

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  That the effects of smoking should be measured in pack-years: misconceptions 4.

Authors:  J Peto
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

View more
  26 in total

1.  Relationship between physical activity/exercise habits and the frequency of new onset of lifestyle-related diseases after the Great East Japan Earthquake among residents in Fukushima: the Fukushima Health Management Survey.

Authors:  Fumikazu Hayashi; Tetsuya Ohira; Kanako Okazaki; Hironori Nakano; Akira Sakai; Mitsuaki Hosoya; Michio Shimabukuro; Atsushi Takahashi; Junichiro Kazama; Seiji Yasumura; Shigeatsu Hashimoto; Yukihiko Kawasaki; Gen Kobashi; Hitoshi Ohto; Kenji Kamiya
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

2.  Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes.

Authors:  Maija Feodoroff; Valma Harjutsalo; Carol Forsblom; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-09-18       Impact factor: 10.122

3.  Support Vector Hazards Machine: A Counting Process Framework for Learning Risk Scores for Censored Outcomes.

Authors:  Yuanjia Wang; Tianle Chen; Donglin Zeng
Journal:  J Mach Learn Res       Date:  2016-08-01       Impact factor: 3.654

4.  Racial/Ethnic Differences in Duration of Smoking Among Former Smokers in the National Health and Nutrition Examination Surveys.

Authors:  Miranda R Jones; Corinne E Joshu; Ana Navas-Acien; Elizabeth A Platz
Journal:  Nicotine Tob Res       Date:  2018-02-07       Impact factor: 4.244

5.  Both Duration and Pack-Years of Tobacco Smoking Should Be Used for Clinical Practice and Research.

Authors:  Roy A Pleasants; M Patricia Rivera; Stephen L Tilley; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2020-07

6.  Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.

Authors:  Surya P Bhatt; Young-Il Kim; Kathy F Harrington; John E Hokanson; Sharon M Lutz; Michael H Cho; Dawn L DeMeo; James M Wells; Barry J Make; Stephen I Rennard; George R Washko; Marilyn G Foreman; Donald P Tashkin; Robert A Wise; Mark T Dransfield; William C Bailey
Journal:  Thorax       Date:  2018-01-11       Impact factor: 9.139

7.  Long-term trends and predictors of smoking behaviors among men following first-ever ischemic stroke.

Authors:  Li-Sha Hou; Xu-Dong Du; Ji-Jie Li; Ping Zhu; Pei-Jing Yan; Feng-Yu Zhan; Mu-Ke Zhou; Cai-Rong Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

8.  Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Maki Inoue-Choi; Linda M Liao; Carolyn Reyes-Guzman; Patricia Hartge; Neil Caporaso; Neal D Freedman
Journal:  JAMA Intern Med       Date:  2017-01-01       Impact factor: 21.873

Review 9.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

10.  Increased Morbidity and Mortality in Hypertensive Patients With Substance Use Disorders: Electronic Health Record Findings.

Authors:  Theresa Winhusen; Jeff Theobald; David C Kaelber; Daniel Lewis
Journal:  J Stud Alcohol Drugs       Date:  2020-07       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.